What Allumia Ventures does

Allumia Ventures is an independent healthcare-focused venture capital firm that invests in commercial-stage companies across Digital Health, MedTech, and tech-enabled healthcare services. Originally launched in 2015 as Providence Ventures, the corporate venture arm of Providence health system, it spun off in January 2025 to become an independent firm under the Allumia Ventures name while retaining Providence as its Anchor Limited Partner with a $150M commitment to Fund III over ten years. The firm invests $5-15M initially per company (up to $15M total), typically leading or co-leading Series A-C rounds and taking board seats, with a current portfolio of 28-30 active investments across digital health, behavioral health, value-based care, healthcare IT, and medical devices.

Allumia's core competitive proposition is its LP network of 100+ healthcare organizations, anchored by Providence, which enables 100% of portfolio companies to secure partnerships with strategic LPs and provides approximately 100 company-to-investor introductions annually. The firm's GTM motion is enterprise relationship-driven, leveraging direct outreach, LP referrals, and the team's deep healthcare operating backgrounds (Managing Partner Jeff Stolte previously at Ascension Ventures; Partners Dan Galles from HLM Venture Partners and Branden Fini from Transformation Capital). Allumia generates returns through traditional VC fund economics, collecting management fees on committed capital and carried interest on exits, and has recorded 16 successful exits to date including notable 2025 liquidity events across Protenus, IRIS, Omada Health IPO, Xealth, Kyruus, and Press Ganey.

The firm operates from four U.S. offices (Seattle, San Francisco, New York City opened in 2025, and Salt Lake City) with a lean core team of seven investment professionals plus three advisors, supported by an inaugural Advisory Board formed in October 2025 with former senior executives from Blue Shield of California, Providence, and Froedtert ThedaCare Health.

Name

Allumia Ventures

Legal name

Allumia Ventures

Website

https://allumiaventures.com

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

51–100 employees

Short description

Allumia Ventures is an independent healthcare venture capital firm spun off from Providence in 2025, investing $5-15M in Series A-C digital health, MedTech, and tech-enabled services companies. It leverages a 100+ healthcare LP network anchored by Providence to drive partnerships for its 28-30 portfolio companies.

Ownership category

akta.pro rank

Product category

Healthcare Venture Capital

NAICS

Portfolio Management and Investment Advice (52394), Portfolio Management and Investment Advice (523940), Miscellaneous Financial Investment Activities (523999)

SIC

Investment Advice (6282)

akta.pro primary industry

Multi-Sector / Generalist Growth Equity (FSANACAO)

Keywords

• Venture capital
• Healthcare investing
• Growth equity
• Medtech investment
• Digital health funding

Headquarters

HQ city

Seattle

HQ country

United States

HQ region

North America

Offices4 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Venture Capital Fund Management: Allumia generates returns through traditional VC fund management, collecting management fees and carried interest from their investment funds. They manage capital for Providence (Anchor LP with $150M commitment) and other strategic LP healthcare organizations, deploying capital into portfolio companies and generating returns through exits.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels5 records

Core offering

Allumia Ventures is an independent healthcare venture capital firm that makes Series A–C equity investments of $5–15M into commercial-stage healthcare technology, tech-enabled services, and MedTech companies. Portfolio companies receive board participation, operational guidance, and facilitated introductions to the firm's strategic LP network of 100+ healthcare organizations, including Anchor LP Providence with a $150M commitment.

Product overview

Allumia Ventures is a healthcare venture capital firm, not a product company. It does not offer its own products or services. The firm identifies and invests in best-in-class commercial-stage healthcare companies that leverage technology to address the industry's most pressing challenges. Its investment focus spans Digital Health, Tech-enabled Healthcare Services, and MedTech across commercial-stage companies (typically Series A-C) with investment amounts of $5-15M.

Differentiator

Problem solved

Functional benefit

Quantifiable outcome

• 100% of portfolio companies partnered with strategic LP base
• +2 more outcomes

Named customers3 records

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• Portfolio Companies (28 investments)coreStrategic or Co-development PartnerActive portfolio includes Affect, Arrive Health, AVIA, Binary Fountain, Bolder Surgical, Collective Medical, DexCare, Gauss Surgical, Greater Good Health, InDemand Interpreting, IRIS, Kno2, Kyruus, Livara, Lyra, MacroHealth, N-of-One, Omada, One Medical, OrthAlign, Praia Health, Press Ganey, Protenus, Ready Set Food!, Sqord, TailorMed, Trilliant, Twistle, Wildflower Health, Xealth. 100% of portfolio has partnered with LP base.

Scale indicators6 records

Recent moves8 records

Expansion highlights5 records

Direct peers

• Echo Health Ventures: Strategic healthcare VC formed by Cambia Health Solutions and Blue Cross NC, investing across commercial-stage digital health and health services. Directly analogous to Allumia's prior corporate-VC model with strategic health plan LPs.
• ARCH Venture Partners: Healthcare- and technology-focused VC investing across biotech, MedTech, and digital health. Comparable healthcare specialization though typically earlier stage and larger fund size than Allumia.
• 7wireVentures: Digital health-focused VC investing in consumer health, employer health, and care delivery. Closely comparable to Allumia's digital health and tech-enabled services thesis with a similar check size.
• Oak HC/FT: Specialist venture and growth equity firm focused exclusively on healthcare and financial services technology. Closely comparable to Allumia in sector focus and growth-stage Series A-C check size, though with larger fund AUM.
• Ascension Ventures: Strategic healthcare VC affiliated with Ascension Health, investing across health IT, tech-enabled services, and medical devices. Directly comparable to Allumia's prior Providence Ventures structure; notably, Allumia Managing Partner Jeff Stolte previously worked at Ascension Ventures.
• Flare Capital Partners: Early- to growth-stage VC exclusively focused on healthcare technology and digital health. Comparable sector specialization and stage focus to Allumia, with strong strategic LP ecosystem among payers and providers.
• Town Hall Ventures: Healthcare-focused VC investing in companies serving underserved populations and value-based care. Comparable sector concentration and growth-stage focus, with similar strategic-LP-driven distribution thesis.

Regional players

• CVS Health Ventures: Corporate venture arm of CVS Health investing in digital health, care delivery, and tech-enabled services. Comparable strategic-VC structure and healthcare-only thesis to Allumia, anchored by a single large strategic LP.

Broad incumbents

• Optum Ventures: Strategic venture arm of UnitedHealth Group/Optum investing in healthcare AI, digital health, and tech-enabled services. Comparable to Allumia in healthcare-only focus and large strategic LP parent, but with materially larger AUM and proprietary payer-provider data assets.
• General Catalyst: Large multi-stage VC with a significant healthcare practice (HATCo, healthcare transformation). Overlaps with Allumia in digital health and care delivery but operates with materially larger AUM and broader sector mandate.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/providence-ventures

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments36 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Allumia Ventures